It was a question raised by this
to the safety...well look at the recent problem with vioxx as an example.Originally Posted by hobbes
to the effectiveness it was more the type of drugs being approved
many new drugs are developed to make drug companies and their shareholders more profit, not to offer new treatments and certainly not to offer cures.
only roughly15%-20% (i can't remember the artical i read that but i think it was time magazine) of drugs approved by the FDA in the decade upto 2000 were cited as offering significant clinical advantage over drugs already on the market. a vast majority of research & developement dollars are spent on developing drugs that simply compete with existing drugs already on the market, so drug company A can try to rip sales away from drug company B. What’s more, most drug makers won’t even consider developing drugs for rare diseases because there is little promise of profit.
Bookmarks